Jadidi-Niaragh F - Search Results

1

The role of exosomal non-coding RNAs in aging-related diseases.

Dolati S, Shakouri SK, Dolatkhah N, Yousefi M, Jadidi-Niaragh F, Sanaie S. Dolati S, et al. Biofactors. 2021 May;47(3):292-310. doi: 10.1002/biof.1715. Epub 2021 Feb 23. Biofactors. 2021. PMID: 33621363 Review.

2

Increased frequency of CD8+ and CD4+ regulatory T cells in chronic lymphocytic leukemia: association with disease progression.

Jadidi-Niaragh F, Yousefi M, Memarian A, Hojjat-Farsangi M, Khoshnoodi J, Razavi SM, Jeddi-Tehrani M, Shokri F. Jadidi-Niaragh F, et al. Cancer Invest. 2013 Feb;31(2):121-31. doi: 10.3109/07357907.2012.756110. Epub 2013 Jan 3. Cancer Invest. 2013. PMID: 23286587

3

The role of natural killer T cells in B cell malignancies.

Ghalamfarsa G, Hadinia A, Yousefi M, Jadidi-Niaragh F. Ghalamfarsa G, et al. Tumour Biol. 2013 Jun;34(3):1349-60. doi: 10.1007/s13277-013-0743-x. Epub 2013 Mar 19. Tumour Biol. 2013. PMID: 23504588 Review.

4

Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia.

Ghalamfarsa G, Jadidi-Niaragh F, Hojjat-Farsangi M, Asgarian-Omran H, Yousefi M, Tahmasebi F, Khoshnoodi J, Razavi SM, Saboor-Yaraghi AA, Rabbani H, Jeddi-Tehrani M, Shokri F. Ghalamfarsa G, et al. Cytokine. 2013 Jun;62(3):439-45. doi: 10.1016/j.cyto.2013.03.023. Epub 2013 Apr 9. Cytokine. 2013. PMID: 23579027

5

Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.

Jadidi-Niaragh F, Ghalamfarsa G, Yousefi M, Tabrizi MH, Shokri F. Jadidi-Niaragh F, et al. Tumour Biol. 2013 Aug;34(4):2031-9. doi: 10.1007/s13277-013-0832-x. Epub 2013 May 17. Tumour Biol. 2013. PMID: 23681798 Review.

6

Immunomodulatory characteristics of mesenchymal stem cells and their role in the treatment of multiple sclerosis.

Gharibi T, Ahmadi M, Seyfizadeh N, Jadidi-Niaragh F, Yousefi M. Gharibi T, et al. Cell Immunol. 2015 Feb;293(2):113-21. doi: 10.1016/j.cellimm.2015.01.002. Epub 2015 Jan 10. Cell Immunol. 2015. PMID: 25596473 Review.

7

The use of nanoparticles as a promising therapeutic approach in cancer immunotherapy.

Hosseini M, Haji-Fatahaliha M, Jadidi-Niaragh F, Majidi J, Yousefi M. Hosseini M, et al. Artif Cells Nanomed Biotechnol. 2016 Jun;44(4):1051-61. doi: 10.3109/21691401.2014.998830. Epub 2015 Jan 23. Artif Cells Nanomed Biotechnol. 2016. PMID: 25612903 Free article. Review.

8

Immunotherapeutic approaches for cancer therapy: An updated review.

Kazemi T, Younesi V, Jadidi-Niaragh F, Yousefi M. Kazemi T, et al. Artif Cells Nanomed Biotechnol. 2016 May;44(3):769-79. doi: 10.3109/21691401.2015.1019669. Epub 2015 Mar 24. Artif Cells Nanomed Biotechnol. 2016. PMID: 25801036 Free article. Review.

9

The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.

Yousefi M, Movassaghpour AA, Shamsasenjan K, Ghalamfarsa G, Sadreddini S, Jadidi-Niaragh F, Hojjat-Farsangi M. Yousefi M, et al. Future Oncol. 2015;11(10):1567-82. doi: 10.2217/fon.14.298. Future Oncol. 2015. PMID: 25963433 Review.

10

Comparative human and mouse antibody responses against tetanus toxin at clonal level.

Yousefi M, Younesi V, Bayat AA, Jadidi-Niaragh F, Abbasi E, Razavi A, Khosravi-Eghbal R, Asgarian-Omran H, Shokri F. Yousefi M, et al. J Immunotoxicol. 2016;13(2):243-8. doi: 10.3109/1547691X.2015.1046572. Epub 2015 May 20. J Immunotoxicol. 2016. PMID: 25990600 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters